MiR-4753-5p for diagnosing osteoporosis of postmenopausal women
An osteoporosis, women's technology, applied in the field of biomedicine, can solve the problem of not being able to use the screening of osteoporosis patients
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0047] Example 1 Sequencing and screening of miRNAs related to osteoporosis in postmenopausal women
[0048] 1. Research objects and sample collection
[0049] 3 cases of postmenopausal women with osteoporosis and 3 normal postmenopausal women, normal postmenopausal women served as controls. The clinical information is shown in Table 1.
[0050] Table 1 Clinical information of study subjects
[0051]
[0052] The subjects were required to fast for at least 12 hours. At room temperature from 7:00 to 8:00 the next morning, 10ml of venous blood was drawn into an ethylenediaminetetraacetic acid (EDTA) anticoagulant tube, and peripheral blood mononuclear cell PBMCs were extracted, and 1ml Trizol reagent was added. (Invitrogen), mix well and store the specimen at -80°C for RNA extraction. All blood samples and pathological results should be true and reliable, the study was approved by the ethics committee, and the patient informed consent.
[0053] 2. RNA extraction from blood monocytes
[...
Embodiment 2
[0080] Example 2 QPCR verification of differentially expressed miR-4753-5p
[0081] 1. According to the sequencing results in Example 1, miR-4753-5p was selected for large sample QPCR verification. According to the sample collection method in Example 1, 30 normal postmenopausal women and 30 postmenopausal women with osteoporosis were selected for separation and preservation of blood mononuclear cells.
[0082] 2. The RNA extraction process is the same as in Example 1.
[0083] 3. Reverse transcription: mix 10pg-1μg of total RNA template with 2μl 10* buffer, 2μl dATP (10mM), 0.5μl polyA polymerase, 0.5μl ribonuclease (RNase) inhibitor and RNase free water ) Mix, the final volume is 20μl, and incubate at 37°C for 1h. Then add 1μl 0.5μg / μl Oligo(dT) specific RT primer to the reaction tube, incubate at 70℃ for 5min and immediately incubate on ice for at least 2min to break the secondary structure of RNA and primer. Finally, the above 20μl reaction mixture and 4μl 5* buffer, 1μl dNTP (...
PUM

Abstract
Description
Claims
Application Information

- R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com